Abstract
Background and purpose
Oral mucositis is a severe and dose limiting early side effect of radiotherapy for head-and-neck tumors. This study was initiated to determine the effect of bone marrow- and mesenchymal stem cell transplantation on oral mucositis (mouse tongue model) induced by fractionated irradiation.
Material and methods
Daily fractionated irradiation (5 × 3 Gy/week) was given over 1 (days 0–4) or 3 weeks (days 0–4, 7–11, 14–18). Each protocol was terminated (day 7 or 21) by graded test doses (5 dose groups, 10 animals each) in order to generate complete dose–effect curves. The incidence of mucosal ulceration, corresponding to confluent mucositis grade 3 (RTOG/EORTC), was analyzed as the primary, clinically relevant endpoint. Bone marrow or mesenchymal stem cells were transplanted intravenously at various time points within these fractionation protocols.
Results
Transplantation of 6 × 106, but not of 3 × 106 bone marrow stem cells on day − 1, + 4, + 8, + 11 or + 15 significantly increased the ED50 values (dose, at which an ulcer is expected in 50 % of the mice); transplantation on day + 2, in contrast, was ineffective. Mesenchymal stem cell transplantation on day − 1, 2 or + 8 significantly, and on day + 4 marginally increased the ED50 values.
Conclusion
Transplantation of bone marrow or mesenchymal stem cells has the potential to modulate radiation-induced oral mucositis during fractionated radiotherapy. The effect is dependent on the timing of the transplantation. The mechanisms require further investigation.
Zusammenfassung
Hintergrund und Ziel
Die orale Mukositis ist eine schwere und dosislimitierende frühe Nebenwirkung der Strahlentherapie von Kopf-Hals-Tumoren. Ziel der vorliegenden Arbeit war die Untersuchung des Effekts der Transplantation von Knochenmarks- oder mesenchymalen Stammzellen auf die durch fraktionierte Bestrahlung induzierte orale Mukositis im Modell der Mäusezunge.
Material und Methoden
Die tägliche fraktionierte Bestrahlung (5-mal 3 Gy/Woche) wurde über eine (Tage 0–4) oder über 3 Wochen (Tage 0–4, 7–11, 14–18) appliziert. Abschließend erfolgte die lokale Bestrahlung (Tag 7 oder 21) in gestaffelten Testdosen (5 Dosisgruppen mit je 10 Tieren) zur Generierung kompletter Dosis-Effekt-Kurven. Die Inzidenz von Schleimhautulzera, entsprechend einer konfluenten Grad-3-Mukositis (RTOG/EORTC), wurde als primärer, klinisch relevanter Endpunkt analysiert. Knochenmark oder mesenchymale Stammzellen wurden zu verschiedenen Zeitpunkten während dieser Fraktionierungsprotokolle intravenös transplantiert.
Ergebnisse
Die Transplantation von 6 × 106, nicht jedoch von 3 × 106 Knochenmarkszellen, an den Tagen − 1, + 4, + 8, + 11 oder + 15 der fraktionierten Bestrahlung erhöhte die ED50-Werte (Dosis, bei der bei 50 % der Tiere ein Schleimhautulkus zu erwarten ist) signifikant; im Gegensatz dazu war die Transplantation an Tag + 2 wirkungslos. Die mesenchymale Stammzelltransplantation führte an den Tagen − 1, + 4 oder + 8 zu einer signifikanten und an Tag +4 zu einer marginalen Erhöhung der ED50-Werte.
Schlussfolgerung
Die Transplantation von Knochenmark bzw. mesenchymalen Stammzellen hat das Potential, die durch Strahlentherapie induzierte orale Mukositis zu beeinflussen. Dieser Effekt ist abhängig vom Zeitpunkt der Transplantation. Die Mechanismen bedürfen einer weiteren Abklärung.
References
Albert M, Schmidt M, Cordes N, Dörr W (2012) Modulation of radiation-induced oral mucositis (mouse) by selective inhibition of beta1 integrin. Radiother Oncol 104:230–234
Bensidhoum M, Gobin S, Chapel A et al (2005) Therapeutic effect of human mesenchymal stem cells in skin after radiation damage. J Soc Biol 199:337–431
Bese NS, Hendry J, Jeremic B (2007) Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 68:654–661
Bütof R, Baumann M (2013) Time in radiation oncology—keep it short! Radiother Oncol 106:271–275
Camargo FD, Chambers SM, Goodell MA (2004) Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif 37:55–65
Chhabra P, Brayman KL (2013) Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med 2:328–336
Clements WK, Traver D (2013) Signalling pathways that control vertebrate haematopoietic stem cell specification. Nat Rev Immunol 13:336–348
Cvek J, Kubes J, Skacelikova E et al (2012) Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70–75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study. Strahlenther Onkol 188:666–670
Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875–884
Dörr W (2003) Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 79:531–537
Dörr W (2009) Pathogenesis of normal-tissue side-effects. In: Joiner M, Van der Kogel A (eds) Basic clinical radiobiology, 4th edn. Hodder Arnold, London pp 169–190
Dörr W (2009) Biological response modifiers: normal tissues. In: Joiner M, Van der Kogel A (eds) Basic clinical radiobiology, 4th edn. Hodder Arnold, London pp 301–315
Dörr W, Kummermehr J (1990) Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol 17:249–259
Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223–231
Dörr W, Herskind C (2012) Radiation biology of normal tissues. Scientific progress and perspectives. Strahlenther Onkol 188(Suppl 3):295–298
Dörr W, Heider K, Spekl K (2005) Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF. Int J Radiat Biol 81:557–565
Dörr W, Reichel S, Spekl K (2005) Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 75:99–105
Dörr W, Dolling-Jochem I, Baumann M, Herrmann T (1997) The therapeutic management of radiogenic oral mucositis. Strahlenther Onkol 173:183–192
Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68:1110–1120
Elting LS, Keefe DM, Sonis ST et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113:2704–2713
Francois S, Mouiseddine M, Mathieu N et al (2007) Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model. Ann Hematol 86:1–8
Frenette PS, Pinho S, Lucas D, Scheiermann C (2013) Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol 31:285–316
Gehrisch A, Dörr W (2007) Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Strahlenther Onkol 183:36–42
Gogolek J, Schuemer R, Ströhlein G (eds) (1992) Datenverarbeitung und statistische Auswertung mit SAS. Einführumg in das Programmsystem, Datenmanagement und Auswertung, vol 1. Fischer, Stuttgart
Haagen J, Krohn H, Röllig S et al (2009) Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies. Radiother Oncol 92:472–476
Hansson EM, Lendahl U (2013) Regenerative medicine for the treatment of heart disease. J Intern Med 273:235–245
Harris DJ (2006) Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manag 2:251–258
Herrmann T, Baumann M (2005) Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation. Strahlenther Onkol 181:65–76
Kolios G, Moodley Y (2013) Introduction to stem cells and regenerative medicine. Respiration 85:3–10
Kotton DN, Ma BY, Cardoso WV et al (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128:5181–5188
Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin North Am 52:61–77, viii
Maxson S, Lopez EA, Yoo D et al (2012) Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med 1:142–149
Murphy BA (2007) Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol 5:13–21
Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705
Pabst S, Spekl K, Dörr W (2004) Changes in the effect of dose fractionation during daily fractionated irradiation: studies in mouse oral mucosa. Int J Radiat Oncol Biol Phys 58:485–492
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Poulsom R, Forbes SJ, Hodivala-Dilke K et al (2001) Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229–235
Rosenthal DI (2007) Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol 5:23–31
Rosenthal DI, Trotti A (2009) Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19:29–34
Russo G, Haddad R, Posner M, Machtay M (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 13:886–898
SAS Institute C, N.C.:, USA. SAS/STAT 9.2 User Guide. 2008
Schuemer R, Ströhlein G, Gogolek J (1990) Datenverarbeitung und statistische Auswertung mit SAS. Komplexe statistische Analyseverfahren, vol 2. Fischer, Stuttgart
Sumita Y, Liu Y, Khalili S et al (2011) Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation. Int J Biochem Cell Biol 43:80–87
Treister N, Sonis S (2007) Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg 15:123–129
Vieyra DS, Jackson KA, Goodell MA (2005) Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev 1:65–69
Woolthuis CM, Haan G de, Huls G (2011) Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects? Curr Opin Immunol 23:512–517
Wygoda A, Rutkowski T, Hutnik M et al (2013) Acute mucosal reactions in patients with head and neck cancer: three patterns of mucositis observed during radiotherapy. Strahlenther Onkol 189:547–551
Xu YL, Liu YL, Wang Q et al (2012) Intravenous transplantation of mesenchymal stem cells attenuates oleic acid induced acute lung injury in rats. Chin Med J (Engl) 125:2012–2018
Acknowledgments
This project was supported by the European Commission; contract number LSHC-CT-2004-503436 (“FIRST”). The authors are grateful to Ms. D. Pfitzmann and the medical physicists of the Dept. of Radiotherapy and Radiation Oncology at the Medical Faculty Carl Gustav Carus of the Technical University Dresden for skillful assistance.
Compliance with ethical guidelines
Conflict of interest. M. Schmidt, J. Haagen, R. Noack, A. Siegemund, P. Gabriel, and W. Dörr state that there are no conflicts of interest. All national guidelines on the care and use of laboratory animals have been followed and the necessary approval was obtained from the relevant authorities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmidt, M., Haagen, J., Noack, R. et al. Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation. Strahlenther Onkol 190, 399–404 (2014). https://doi.org/10.1007/s00066-013-0510-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-013-0510-3
Keywords
- Oral mucositis
- Fractionated radiotherapy
- Bone marrow transplantation
- Mesenchymal stem cells
- Mouse tongue model